Home

MURRAY A GOLDBERG

CIK 1226435 · SVP Administration & Asst Secr · last filed 2023-01-23

MURRAY A GOLDBERG is a SVP Administration & Asst Secr who has filed 58 SEC Form 4 insider transactions across 4 companies since 2007. Across all open-market trades the lifetime net is −$56.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $54.8M across reported positions. 61 SEC filings were submitted jointly with REGENERON PHARMACEUTICALS, INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$54.77M

Companies

4

Total Filings

58

Lifetime Open-Market Net

-$56.70M

Filer Profile

Reported Address
2030 MAIN STREET, SUITE 1500
IRVINE, CA 92614
Related Filers
REGENERON PHARMACEUTICALS, INC. — 61 joint filings, latest 2014-12-18
TEVA PHARMACEUTICAL INDUSTRIES LTD — 3 joint filings, latest 2019-06-13
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Old Ayala, Inc (AYLA) Delisted Director — $0.50 — $0 2 2022-06-15
AERIE PHARMACEUTICALS INC (AERI) Delisted Director 36,050 $15.25 $549.8K $0 6 2020-05-20
TEVA Director — $37.09 — $0 2 2019-06-13
REGN SVP Administration & Asst Secr 70,086 $781.49 $54.77M -$56.70M 46 2014-12-18

Recent Filings

58 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2023-01-23 — Disp (D) — $0
2023-01-23 — Grant (A) — $0
2022-06-15 Old Ayala, Inc (AYLA) Delisted Grant (A) — $0 EDGAR
2021-06-14 Old Ayala, Inc (AYLA) Delisted Grant (A) — $0 EDGAR
2020-05-20 AERIE PHARMACEUTICALS INC (AERI) Delisted Exer (M) +28,000 $88.2K EDGAR
2019-06-13 TEVA Grant (A) — $0 EDGAR
2019-05-24 AERIE PHARMACEUTICALS INC (AERI) Delisted Grant (A) +1,750 $0 EDGAR
2018-06-08 AERIE PHARMACEUTICALS INC (AERI) Delisted Grant (A) +1,750 $0 EDGAR
2018-06-07 TEVA Grant (A) — $0 EDGAR
2017-06-09 AERIE PHARMACEUTICALS INC (AERI) Delisted Grant (A) +1,150 $0 EDGAR
Showing 1–10 of 58
Page 1 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.